RecruitingNCT06817408
Dynamics of Organ Damage and Immune Exhaustion During Sepsis
Cell-free DNA Epigenomics to Track the Dynamics of Organ Damage and Immune Exhaustion During Sepsis
Sponsor
Mayo Clinic
Enrollment
1,000 participants
Start Date
Mar 25, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective, non-randomized study investigating if organ damage and immune changes can be measured by liquid biopsy NGS through advanced analytical methods.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- • Patients who've developed a shocked state (Hypotension or Lactate grade \>4) or Clinical Concern
Exclusion Criteria3
- \<18 years of age
- Pregnant Women
- Nursing women
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERObservation
One additional blood draw in the Emergency Department as part of their standard of care visit.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06817408
Related Trials
Febrile Infants Swedish Study
NCT0713475111 locations
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
NCT0685464020 locations
Gelaspan vs Crystalloid Therapy in Sepsis
NCT071724519 locations
Sepsis: From Syndrome to Personalized Care
NCT042039791 location
Expression Profiles of Integrin αDβ2 on Neutrophils in Sepsis
NCT041032811 location